Abstracts

Click on the abstract title to open the abstract in a new window.

• Uptake of 60-day prescriptions in different Australian population groups: A co-designed and co-produced research project
  K Hall, Adelaide University; M Gillies; R Sharma; S Marsh; J Janetzki; M Litchfield; J Carson; S Pearson; N Pratt
• Co-desigining the Coordinated Medication Prescription and Adherence Support System (COMPASS) for survivors of stroke: preliminary results
  L Dalli, Monash; C Burns; T Arfaras; M Kilkenny; S Talic; D Cadilhac; J Ayre; C Ferguson; T Kleinig; A Livori; T Purvis
• timespan.eu: Australian pharmacoepidemiologists plugging in to a large-scale European research collaboration
  M Gillies, UNSW
• Considerations when conducting research with representatives from industry-funded health consumer groups: insights from an Australian national survey
  D Drabarek, USyd; S Talukder; J Mackson; A Brown; L Parker; J Chin; B Spongberg-Ross; T Johnson; F Held; K Chiu; B Mintzes
• The APAC-VALUE study: A global characterisation study of VALproate Utilisation and Exposure among women and men of childbearing age
  J Janetzki, Adelaide University; B Varney; N Pratt; on behalf of the OHDSI APAC-VALUE Investigators
  
  

Click on the abstract title to open the abstract in a new window.

• Exploring barriers and facilitators to concomitant oral retinoid and contraceptive use in Australia among woman of childbearing age: Preliminary findings from the WISE-CORE study
  S McMillian; D Hope; M Porter; B Stoddart; E Veysey; B Gilsenan; V Slavin; K Cheung; J Cavanagh; P Stehlik, Griffith University
• Beyond the data: understanding medicine decisions for ADHD in pregnancy
  D Russell, UWA; E Kelty; C Wyrwoll; D Barrington
• Identifying pregnancy episodes in New South Wales using the Medicines Intelligence Data Platform
  C Bruno, USyd; L Gerhardy; D Bond; S Pont; A Shand; N Nassar

Click on the abstract title to open the abstract in a new window.

• Novel psychoactive substance use in Australian prison settings
  C Cumming, UWA; D McCutcheon; J Schumann; C Weber; E Kotkis; J Smith; T Jiranantakan; D Fatovich 
• Recovery beyond symptoms: A retrospective observational study of quality of life following medicinal cannabis treatment for anxiety disorders
  L Roberts; C Cumming, UWA; C Budgeon; D Preen; K Lee  
• Has SafeScript NSW reduced benzodiazepine and opioid poisoning? An interrupted time series analysis
  S Joffe, USyd; N Buckley; J Raubenheimer

Click on the abstract title to open the abstract in a new window.

• Short-term risk of falls among initiators of controlled-release tapentadol versus oxycodone
  X Camacho, UNSW; A Schaffer; J  Brett; R  Hopkins; N  Gisev; S Marsh; K Filion; N Pratt; D Henry; S Pearson
• Real-world discontinuation rates of GLP-1 receptor agonists for type 2 diabetes are high in Australia
  T Milder, UNSW; J Carson; J de Oliveira Costa; J Greenfield; R Day; J Ludington; B Neuen; M Jun; N Pratt; S Pearson; M Falster
• Real-world olaparib use and outcomes in ovarian cancer and a comparison with the key clinical trials (abstract not to be published)
  N Meagher, UNSW; Y Chen Lee; J Frawley Werger; J Ruiz; M Litchfield; A DeFazio; P Webb; M Friedlander; S Pearson; B Daniels